Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis ; volume:21 ; number:1 ; day:10 ; month:10 ; year:2022 ; pages:1-15 ; date:12.2022
Molecular cancer ; 21, Heft 1 (10.10.2022), 1-15, 12.2022
- Urheber
-
Renaud, Emilie
Riegel, Kristina
Romero, Rossana
Suryamohan, Kushal
Distler, Ute
Tenzer, Stefan
Schad, Arno
Musholt, Thomas J.
Rajalingam, Krishnaraj
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-022-01665-y
- URN
-
urn:nbn:de:101:1-2022122721024944458948
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Renaud, Emilie
- Riegel, Kristina
- Romero, Rossana
- Suryamohan, Kushal
- Distler, Ute
- Tenzer, Stefan
- Schad, Arno
- Musholt, Thomas J.
- Rajalingam, Krishnaraj
- SpringerLink (Online service)
Ähnliche Objekte (12)
SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF
Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer
BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report
Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF
Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer
BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report
Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF
Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer
BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report
Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma